Marshall Wace’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-420,326
| Closed | -$727K | – | 2347 |
|
|
2024
Q2 | $727K | Buy |
420,326
+268,763
| +177% | +$465K | ﹤0.01% | 1643 |
|
|
2024
Q1 | $362K | Buy |
151,563
+34,383
| +29% | +$82.2K | ﹤0.01% | 1798 |
|
|
2023
Q4 | $390K | Sell |
117,180
-2,195,026
| -95% | -$7.31M | ﹤0.01% | 1507 |
|
|
2023
Q3 | $8.65M | Buy |
2,312,206
+28,815
| +1% | +$108K | 0.02% | 627 |
|
|
2023
Q2 | $9.75M | Buy |
2,283,391
+1,710,463
| +299% | +$7.3M | 0.02% | 641 |
|
|
2023
Q1 | $3.92M | Buy |
+572,928
| New | +$3.92M | 0.01% | 927 |
|
|
2022
Q4 | – | Sell |
-30,534
| Closed | -$294K | – | 2374 |
|
|
2022
Q3 | $294K | Buy |
+30,534
| New | +$294K | ﹤0.01% | 2239 |
|
|
2021
Q2 | – | Sell |
-34,610
| Closed | -$505K | – | 2157 |
|
|
2021
Q1 | $505K | Buy |
+34,610
| New | +$505K | ﹤0.01% | 1639 |
|
|
2019
Q3 | – | Sell |
-9,339
| Closed | -$207K | – | 1643 |
|
|
2019
Q2 | $207K | Buy |
+9,339
| New | +$207K | ﹤0.01% | 1209 |
|
|
2018
Q4 | – | Sell |
-237,182
| Closed | -$3.91M | – | 1604 |
|
|
2018
Q3 | $3.91M | Buy |
237,182
+210,824
| +800% | +$3.48M | 0.03% | 517 |
|
|
2018
Q2 | $369K | Buy |
+26,358
| New | +$369K | 0.01% | 608 |
|
|
2017
Q1 | – | Sell |
-36,303
| Closed | -$1.02M | – | 373 |
|
|
2016
Q4 | $1.02M | Buy |
+36,303
| New | +$1.02M | 0.01% | 750 |
|